Tetrahydroisoquinoline Compound and Medicinal Use Thereof
申请人:Takahashi Kenji
公开号:US20100022582A1
公开(公告)日:2010-01-28
The present invention provide a tetrahydroisoquinoline compound having a superior ACAT-inhibitory activity and/or anti-oxidation action, particularly, novel compound represented by the formula (I) (wherein each symbol is as described in the specification) and a pharmaceutically acceptable salt thereof.
TETRAHYDROISOQUINOLINE COMPOUND AND MEDICINAL USE THEREOF
申请人:Kyoto Pharmaceutical Industries, Ltd.
公开号:EP1857444A1
公开(公告)日:2007-11-21
The present invention provide a tetrahydroisoquinoline compound having a superior ACAT-inhibitory activity and/or anti-oxidation action, particularly, novel compound represented by the formula (I) (wherein each symbol is as described in the specification) and a pharmaceutically acceptable salt thereof.